Matching slides 41,369
Current window 30,991-31,020
Pages 1,379
Rows per page 30
Component: Calloutclear collectionreset all

Component

30,991-31,020 of 41,369

filter-aware
12
The slide uses a process flow diagram to illustrate the drug discovery pipeline.Absci | Investor Presentation Deck | 26 slides · Absci
Pitch deck Investor relations Beat · Solution1 hit
09
The slide uses a process flow diagram to explain the drug discovery pipeline from patient cohort to manufacturing.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
13
The slide highlights a specific Nature Biomedical Engineering paper as validation of the company's core technology approach.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
16
The slide includes a small schematic icon representing the scatter plot and a callout box emphasizing the necessity of high-quality data for AI training.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
18
The slide explains the methodology behind the dataset used for AI lead optimization, specifically focusing on the combinatorial space of amino acid mutations.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
20
The chart shows density vs -log10Kd, comparing design vs validation vs measured trastuzumab.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
21
The slide highlights the methodology of sampling sequence space and validating predictive models against measured binding affinity.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
22
The chart compares High vs Low Fidelity models with and without pretraining across different training data sizes.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
27
The charts show the progression of antibody variants over generations, highlighting the improvement in ACE score and naturalness metrics.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
29
The slide uses a process flow diagram to show the integration of AI in drug development.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
18
The slide uses a simple problem-solution structure, identifying the clinical gap and the resulting need.Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
22
Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slidesAeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
23
The slide uses a process flow diagram to show the metabolic block (CBS deficiency) and the therapeutic intervention point.Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
25
The slide uses a process flow diagram to represent clinical trial cohorts and study design.Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
08
The slide includes a footer note regarding patient completion rates.Albireo Pharma | Results Presentation Deck | 18 slides · Albireo Pharma
Conference presentation Investor relations Beat · Agitate1 hit
09
Clinical trial data showing efficacy of Odevixibat (Bylvay) vs Placebo.Albireo Pharma | Results Presentation Deck | 18 slides · Albireo Pharma
Conference presentation Investor relations Beat · SolutionLoop · Before After1 hit
10
The chart displays LS Mean (95% CI) with p-value significance markers.Albireo Pharma | Results Presentation Deck | 18 slides · Albireo Pharma
Conference presentation Investor relations Beat · SolutionLoop · Before After1 hit
13
The slide highlights safety data for Odevixibat (Bylvay) over 24 weeks.Albireo Pharma | Results Presentation Deck | 18 slides · Albireo Pharma
Conference presentation Investor relations Beat · Solution1 hit
14
Albireo Pharma | Results Presentation Deck | 18 slidesAlbireo Pharma | Results Presentation Deck | 18 slides · Albireo Pharma
Conference presentation Investor relations Beat · Solution1 hit
17
The slide uses three distinct cards to represent different strategic pillars (regulatory, clinical, commercial).Albireo Pharma | Results Presentation Deck | 18 slides · Albireo Pharma
Conference presentation Investor relations 1 hit
07
The slide uses a 'plus' sign notation to illustrate the merger/combination of three distinct entities into one ecosystem.AlTi | Investor Presentation Deck | 46 slides · Alvarium Tiedemann
Pitch deck Investor relations Loop · Logic Chain1 hit
17
The central circle represents the client, surrounded by six core service pillars.AlTi | Investor Presentation Deck | 46 slides · Alvarium Tiedemann
Pitch deck Investor relations Beat · Solution1 hit
03
The chart highlights a significant negative trend in free cash flow, with a specific callout for an 871% year-over-year decline.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
04
The chart shows negative cash flow values increasing in magnitude over the five quarters.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
05
The chart displays negative values for all periods shown, indicating a cash outflow trend.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
06
The chart illustrates share dilution management over five quarters.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
07
The chart includes a callout for growth metrics and a footnote explaining F/X adjustment methodology.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
08
The bar chart shows growth from $457,965M to $502,191M. The pie chart shows the composition of the $502,191M total.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
09
The chart highlights a significant year-over-year decline in operating income.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
10
The chart highlights a significant year-over-year decline in operating income.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit